Top Analysts Pick: 3 Stocks to Buy Now for Significant Upside

Three stocks to buy now, according to top analysts, include Crinetics Pharmaceuticals (CRNX) with a 159.5% upside, Backblaze (BLZE) with a 102.95% upside, and DraftKings (DKNG) with a 22.37% upside. The stocks received new Buy ratings recently and have significant potential for growth. TipRanks' Analyst Top Stocks tool can help investors find more stocks like these.

Top analysts have recently issued new Buy ratings for three stocks, each with significant upside potential. Crinetics Pharmaceuticals (CRNX) stands out with a 159.5% upside, followed by Backblaze (BLZE) at 102.95%, and DraftKings (DKNG) with a 22.37% upside.

Crinetics Pharmaceuticals (CRNX)

H.C. Wainwright has reiterated its Buy rating and $81.00 price target on Crinetics Pharmaceuticals (CRNX), representing a substantial 159.5% upside from the current price of $31.11 [1]. The research firm highlighted strong enthusiasm from expert endocrinologists toward Crinetics' lead drug candidate, paltusotine. The drug has demonstrated consistent biochemical and symptom control in acromegaly patients, with a once-daily dosing regimen as a key advantage.

Backblaze (BLZE)

Backblaze (BLZE) has also received a new Buy rating, with a 102.95% upside potential. The company recently announced its second quarter 2025 financial results will be released on August 7, 2025 [2]. Backblaze has been recognized for its cost-effective cloud storage solutions, with an independent report by Enterprise Strategy Group (ESG) demonstrating up to 3.2x lower total cost of ownership (TCO) compared to traditional providers [2].

DraftKings (DKNG)

DraftKings (DKNG) received a new Buy rating with a 22.37% upside. The stock has been gaining attention for its growth potential in the sports betting and daily fantasy sports (DFS) sectors. The company continues to expand its offerings and partnerships, contributing to its positive outlook.

Investors seeking more opportunities like these can use the TipRanks' Analyst Top Stocks tool to find additional stocks with strong analyst support.

References:

[1] https://www.investing.com/news/analyst-ratings/hc-wainwright-reiterates-buy-rating-on-crinetics-stock-at-81-price-target-93CH-4143703
[2] https://www.stocktitan.net/news/BLZE/